Delivery Order W81K0220D0003-W81K0222F0079
Award Date 10/1/22
Potential Completion Date 9/30/23
Potential Value $20K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Inseonmedics Inc. has been awarded a $30,850 firm fixed price delivery order for VENTANA HE600 reagents to support the Department of the Army Medical Command's biological defense analytical and archiving capabilities in South Korea. The delivery order exercises the third option year under the Army's indefinite-delivery/indefinite-quantity contract vehicle for laboratory equipment and supplies. No set-aside provisions were applied to this award. The reagents will support continued biological...
- This delivery order for $45,000 was awarded by the Department of the Army Medical Command to Inseonmedics Inc. for the second delivery of VENTANA HE600 reagents under Option Period I of an indefinite-delivery/indefinite-quantity contract vehicle. The reagents will support the Biological Defense Automated Analytical Platform located in South Korea. Performance will take place in South Korea and be completed by September 30, 2021. No set-aside designation was applied to this award to supply...
- The Department of the Army Medical Command awarded a $32,650 firm fixed-price delivery order to Inseonmedics Inc. of South Korea under a blanket purchase agreement for reagents to support the VENTANA HE600 immunohistochemistry staining platform. The reagents will support the U.S. military's laboratory in BDAACH, Korea and must be delivered by September 30, 2020. No set-aside provision was applied to this order to fulfill testing requirements at the Army medical facility in the Republic of...
- The Defense Health Agency awarded a Purchase Order to Inseonmedics Inc. for VENTANA HE600 reagents on October 1, 2024, with a ceiling value of $117,758.00. The order carries no set-aside designation. Work is performed in Oro Valley, Arizona. The order covers base reagents plus four options for the VENTANA HE600 tissue staining system, supporting laboratory and biological defense operations at medical facilities in the Republic of Korea. The ultimate completion date is September 30, 2029. The...
- This is a federal contract award from the Defense Health Agency (DHA) to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, identified as W81K0220D0003|W81K0224F0054, is for the delivery of VENTANA HE600 reagents, which are critical consumables used in immunohistochemistry staining platforms to support military healthcare and biological defense programs at U.S. military medical facilities in South Korea. The contract is a delivery order under an Indefinite...
- <p>The Defense Health Agency awarded a purchase order to Ventana Medical Systems, Inc. for $1.405 million on May 1, 2026, exercising the first option year for reagents and consumables supporting government-owned analyzers. Performance occurs at Fort Hood, Texas, under a firm fixed price structure with completion targeted for September 30, 2030.</p>
- The Defense Health Agency issued a $33,997.95 delivery order to Chenkwang Science on October 1, 2025, for BioMérieux reagents, with completion scheduled for September 30, 2026. The order is issued under the Defense Health Agency's single-award IDV with Chenkwang Science, valued at $232,645.53 and effective through September 30, 2028, which was awarded without full and open competition due to the contractor's unique capabilities in supplying specialized medical reagents. Place of performance is...
- The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on October 1, 2025, for Roche Ventana Medical System platforms (reagents and instruments) for the Department of Pathology, with a ceiling value of $354,964.92 under firm fixed-price terms. Place of performance is Castleton, IN. The order is due for ultimate completion on September 30, 2026. The delivery order was issued without a set-aside designation, procuring diagnostic reagents and consumables for histology...
- The Defense Health Agency issued a $66,316 delivery order to Synyoung Biomedics on October 1, 2025, for reagents for radiometer arterial blood gas analyzers, with ultimate completion on September 30, 2026. The order is issued under a single-award Indefinite Delivery Contract with the Defense Health Agency valued at $421,130 and extending through September 30, 2027. Place of performance is South Korea. The order is firm fixed price with no set-aside. Synyoung Biomedics supplies radiometer blood...
- <p>The Defense Health Agency awarded a purchase order to Siemens Healthcare Diagnostics Inc. for integrated immunoassay and chemistry analyzer reagents and consumables, valued at $661,723.00, effective April 1, 2026, with ultimate completion by September 30, 2030. Performance occurs at Sleepy Hollow, New York. The order is firm fixed price with no set-aside applied.</p>